Minglu Liu

机构：Shenyang Pharmaceutical University

发表论文 48 篇 · 总被引 916 次 · h-index 16

代表论文

• Intracavity generation of glioma stem cell–specific CAR macrophages primes locoregional immunity for postoperative glioblastoma therapy (2022 · Science Translational Medicine · 被引 290)
• Transient secretion of VEGF protein from transplanted hiPSC-CMs enhances engraftment and improves rat heart function post MI (2022 · Molecular Therapy · 被引 57)
• Multi-omics analysis uncovers tumor ecosystem dynamics during neoadjuvant toripalimab plus nab-paclitaxel and S-1 for esophageal squamous cell carcinoma: a single-center, open-label, single-arm phase 2 trial (2023 · EBioMedicine · 被引 54)
• Nanjing Yunjin intelligent question-answering system based on knowledge graphs and retrieval augmented generation technology (2024 · Heritage Science · 被引 38)
• Intrinsically cryopreservable, bacteriostatic, durable glycerohydrogel inks for 3D bioprinting (2023 · Matter · 被引 38)
• Implantable Microneedle‐Mediated Eradication of Postoperative Tumor Foci Mitigates Glioblastoma Relapse (2024 · Advanced Materials · 被引 32)